Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Collider bias undermines our understanding of COVID-19 disease risk and severity

Gareth J Griffith, Tim T Morris, Matt Tudball, Annie Herbert, Giulia Mancano, Lindsey Pike, View ORCID ProfileGemma C Sharp, View ORCID ProfileTom M Palmer, George Davey Smith, Kate Tilling, Luisa Zuccolo, Neil M Davies, Gibran Hemani
doi: https://doi.org/10.1101/2020.05.04.20090506
Gareth J Griffith
1Medical Research Council Integrative Epidemiology Unit, University of Bristol, BS8 2BN, United Kingdom
2Population Health Sciences, Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tim T Morris
1Medical Research Council Integrative Epidemiology Unit, University of Bristol, BS8 2BN, United Kingdom
2Population Health Sciences, Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matt Tudball
1Medical Research Council Integrative Epidemiology Unit, University of Bristol, BS8 2BN, United Kingdom
2Population Health Sciences, Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annie Herbert
1Medical Research Council Integrative Epidemiology Unit, University of Bristol, BS8 2BN, United Kingdom
2Population Health Sciences, Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giulia Mancano
1Medical Research Council Integrative Epidemiology Unit, University of Bristol, BS8 2BN, United Kingdom
2Population Health Sciences, Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lindsey Pike
1Medical Research Council Integrative Epidemiology Unit, University of Bristol, BS8 2BN, United Kingdom
2Population Health Sciences, Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gemma C Sharp
1Medical Research Council Integrative Epidemiology Unit, University of Bristol, BS8 2BN, United Kingdom
2Population Health Sciences, Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gemma C Sharp
Tom M Palmer
1Medical Research Council Integrative Epidemiology Unit, University of Bristol, BS8 2BN, United Kingdom
2Population Health Sciences, Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tom M Palmer
George Davey Smith
1Medical Research Council Integrative Epidemiology Unit, University of Bristol, BS8 2BN, United Kingdom
2Population Health Sciences, Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kate Tilling
1Medical Research Council Integrative Epidemiology Unit, University of Bristol, BS8 2BN, United Kingdom
2Population Health Sciences, Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luisa Zuccolo
1Medical Research Council Integrative Epidemiology Unit, University of Bristol, BS8 2BN, United Kingdom
2Population Health Sciences, Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neil M Davies
1Medical Research Council Integrative Epidemiology Unit, University of Bristol, BS8 2BN, United Kingdom
2Population Health Sciences, Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, United Kingdom
3K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, NTNU, Norwegian University of Science and Technology, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gibran Hemani
1Medical Research Council Integrative Epidemiology Unit, University of Bristol, BS8 2BN, United Kingdom
2Population Health Sciences, Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: g.hemani@bristol.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Observational data on COVID-19 including hypothesised risk factors for infection and progression are accruing rapidly, often from non-random sampling such as hospital admissions, targeted testing or voluntary participation. Here, we highlight the challenge of interpreting observational evidence from such samples of the population, which may be affected by collider bias. We illustrate these issues using data from the UK Biobank in which individuals tested for COVID-19 are highly selected for a wide range of genetic, behavioural, cardiovascular, demographic, and anthropometric traits. We discuss the sampling mechanisms that leave aetiological studies of COVID-19 infection and progression particularly susceptible to collider bias. We also describe several tools and strategies that could help mitigate the effects of collider bias in extant studies of COVID-19 and make available a web app for performing sensitivity analyses. While bias due to non-random sampling should be explored in existing studies, the optimal way to mitigate the problem is to use appropriate sampling strategies at the study design stage.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This research has been conducted using the UK Biobank Resource under Application Number 16729. The Medical Research Council (MRC) and the University of Bristol support the MRC Integrative Epidemiology Unit [MC_UU_12013/1, MC_UU_12013/9, MC_UU_00011/1]. NMD is supported by a Norwegian Research Council Grant number 295989. GH is supported by the Wellcome Trust and Royal Society [208806/Z/17/Z].

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All analysis was performed on UK Biobank data

https://github.com/explodecomputer/covid_ascertainment

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted May 20, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Collider bias undermines our understanding of COVID-19 disease risk and severity
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Collider bias undermines our understanding of COVID-19 disease risk and severity
Gareth J Griffith, Tim T Morris, Matt Tudball, Annie Herbert, Giulia Mancano, Lindsey Pike, Gemma C Sharp, Tom M Palmer, George Davey Smith, Kate Tilling, Luisa Zuccolo, Neil M Davies, Gibran Hemani
medRxiv 2020.05.04.20090506; doi: https://doi.org/10.1101/2020.05.04.20090506
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Collider bias undermines our understanding of COVID-19 disease risk and severity
Gareth J Griffith, Tim T Morris, Matt Tudball, Annie Herbert, Giulia Mancano, Lindsey Pike, Gemma C Sharp, Tom M Palmer, George Davey Smith, Kate Tilling, Luisa Zuccolo, Neil M Davies, Gibran Hemani
medRxiv 2020.05.04.20090506; doi: https://doi.org/10.1101/2020.05.04.20090506

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (227)
  • Allergy and Immunology (500)
  • Anesthesia (110)
  • Cardiovascular Medicine (1226)
  • Dentistry and Oral Medicine (205)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (528)
  • Epidemiology (9998)
  • Forensic Medicine (5)
  • Gastroenterology (497)
  • Genetic and Genomic Medicine (2441)
  • Geriatric Medicine (236)
  • Health Economics (479)
  • Health Informatics (1634)
  • Health Policy (750)
  • Health Systems and Quality Improvement (633)
  • Hematology (247)
  • HIV/AIDS (530)
  • Infectious Diseases (except HIV/AIDS) (11854)
  • Intensive Care and Critical Care Medicine (625)
  • Medical Education (251)
  • Medical Ethics (74)
  • Nephrology (267)
  • Neurology (2271)
  • Nursing (139)
  • Nutrition (349)
  • Obstetrics and Gynecology (451)
  • Occupational and Environmental Health (532)
  • Oncology (1244)
  • Ophthalmology (375)
  • Orthopedics (133)
  • Otolaryngology (226)
  • Pain Medicine (154)
  • Palliative Medicine (50)
  • Pathology (324)
  • Pediatrics (728)
  • Pharmacology and Therapeutics (311)
  • Primary Care Research (281)
  • Psychiatry and Clinical Psychology (2279)
  • Public and Global Health (4822)
  • Radiology and Imaging (833)
  • Rehabilitation Medicine and Physical Therapy (488)
  • Respiratory Medicine (650)
  • Rheumatology (283)
  • Sexual and Reproductive Health (237)
  • Sports Medicine (224)
  • Surgery (266)
  • Toxicology (44)
  • Transplantation (124)
  • Urology (99)